Document Mentions (3 shared documents)

EFTA00804474

2 mentions1 same-page

Page ?Same page

gout IMMUNOFIXATION, SERUM INTERPRETATION 5.2 6.9 patients: <6.0 mg/dL NO MONOCLONAL PROTEIN DETECTED TSH 2.44 T4 (THYROXINE), TOTAL 7.6 FREE T4 INDEX (T7) 2.3 T3 UPTAKE 30 SED RATE BY MODIFIED WESTERGREN 11 CBC (INCLUDES DIFF/PLT) WHITE BLOOD CELL COUNT 6.0 RED BLOOD CELL COUNT 5.2

D risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al. JAMA. 2013;310(19): 2061-2068 (http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC

EFTA00804470

2 mentions1 same-page

Page ?Same page

le for diagnosis of diabetes for children. URIC ACID Therapeutic target 6.9 for gout patients: <6.0 mg/dL TSH 2.44 T4 (THYROXINE), TOTAL 7.6 FREE T4 INDEX (T7) 2.3 T3 UPTAKE 30 SED RATE BY MODIFIED WESTERGREN 11 CBC (INCLUDES DIFF/PLT) WHITE BLOOD CELL COUNT 6.0 RED BLOOD CELL COUNT 5.2

EFTA00317114

2 mentions1 same-page

Page ?Same page

h ID: 8573003290851249 Test Name Therapeutic target In Range for gout patients: <6.0 Out Of Range mg/dL TSH 3.41 T4 (THYROXINE), TOTAL 8.3 FREE T4 INDEX (T7) 2.4 T3 UPTAKE 29 SED RATE BY MODIFIED WESTERGREN 6 CBC (INCLUDES DIFF/PLT) WHITE BLOOD CELL COUNT 7.5 RED BLOOD CELL COUNT 5.65